Follow
Puneet Agarwal
Title
Cited by
Cited by
Year
SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells
L Li, T Osdal, Y Ho, S Chun, T McDonald, P Agarwal, A Lin, S Chu, J Qi, ...
Cell stem cell 15 (4), 431-446, 2014
2352014
Mapping distinct bone marrow niche populations and their differentiation paths
SL Wolock, I Krishnan, DE Tenen, V Matkins, V Camacho, S Patel, ...
Cell reports 28 (2), 302-311. e5, 2019
1912019
Mesenchymal niche-specific expression of Cxcl12 controls quiescence of treatment-resistant leukemia stem cells
P Agarwal, S Isringhausen, H Li, AJ Paterson, J He, Á Gomariz, ...
Cell Stem Cell 24 (5), 769-784. e6, 2019
1642019
Osteoblast ablation reduces normal long-term hematopoietic stem cell self-renewal but accelerates leukemia development
M Bowers, B Zhang, Y Ho, P Agarwal, CC Chen, R Bhatia
Blood, The Journal of the American Society of Hematology 125 (17), 2678-2688, 2015
1512015
Inhibition of interleukin-1 signaling enhances elimination of tyrosine kinase inhibitor–treated CML stem cells
B Zhang, S Chu, P Agarwal, VL Campbell, L Hopcroft, HG Jørgensen, ...
Blood, The Journal of the American Society of Hematology 128 (23), 2671-2682, 2016
1192016
Preferential killing of triple-negative breast cancer cells in vitro and in vivo when pharmacological aggravators of endoplasmic reticulum stress are combined with autophagy …
S Thomas, N Sharma, EB Golden, H Cho, P Agarwal, KJ Gaffney, ...
Cancer letters 325 (1), 63-71, 2012
812012
Enhanced targeting of CML stem and progenitor cells by inhibition of porcupine acyltransferase in combination with TKI
A Puneet, B Zhang, H Yinwei, L Cook, Amy, Li, F Mikhail, Y Wang, ...
Blood, 2016
65*2016
SIRT1 regulates metabolism and leukemogenic potential in CML stem cells
A Abraham, S Qiu, BK Chacko, H Li, A Paterson, J He, P Agarwal, M Shah, ...
The Journal of clinical investigation 129 (7), 2685-2701, 2019
632019
Influence of Bone Marrow Microenvironment on Leukemic Stem Cells: Breaking Up an Intimate Relationship
P Agarwal, R Bhatia
Advances in Cancer Research, 2015
522015
CXCR4 signaling has a CXCL12-independent essential role in murine MLL-AF9-driven acute myeloid leukemia
R Ramakrishnan, P Peña-Martínez, P Agarwal, M Rodriguez-Zabala, ...
Cell reports 31 (8), 2020
362020
TNF-α-induced alterations in stromal progenitors enhance leukemic stem cell growth via CXCR2 signaling
P Agarwal, H Li, K Choi, K Hueneman, J He, RS Welner, ...
Cell reports 36 (2), 2021
212021
TIFA and TIFAB: FHA-domain proteins involved in inflammation, hematopoiesis, and disease
M Niederkorn, P Agarwal, DT Starczynowski
Experimental Hematology 90, 18-29, 2020
182020
Novel proteasome-inhibitory syrbactin analogs inducing endoplasmic reticulum stress and apoptosis in hematological tumor cell lines
A Anshu, S Thomas, P Agarwal, TR Ibarra-Rivera, MC Pirrung, ...
Biochemical pharmacology 82 (6), 600-609, 2011
162011
Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AML
J Bennett, C Ishikawa, P Agarwal, J Yeung, A Sampson, E Uible, E Vick, ...
Blood 142 (11), 989-1007, 2023
102023
Microenvironmental CXCL12 deletion enhances Flt3-ITD acute myeloid leukemia stem cell response to therapy by reducing p38 MAPK signaling
NR Anderson, V Sheth, H Li, MW Harris, S Qiu, DK Crossman, H Kumar, ...
Leukemia 37 (3), 560-570, 2023
102023
Role of CXCL12-expressing bone marrow populations in leukemic stem cell regulation
P Agarwal, H Li, AJ Paterson, J He, T Nagasawa, R Bhatia
Blood 128 (22), 26, 2016
82016
Mesenchymal niche-specific expression of Cxcl12 controls quiescence of treatment-resistant leukemia stem cells
P Agarwal, S Isringhausen, H Li, AJ Paterson, J He, Á Gomariz, ...
Cell stem cell 26 (1), 123, 2020
52020
Role of enhanced autophagy in resistance of FLT3-ITD AML stem cells to FLT3 TKI treatment
S Qiu, AJ Paterson, A Abraham, J He, M Shah, P Agarwal, AK Mullen, H Li, ...
Blood 132, 1358, 2018
52018
Inhibition of CML stem cell renewal by the porcupine inhibitor WNT974
P Agarwal, B Zhang, Y Ho, A Cook, L Li, Y Wang, ME Mclaughlin, ...
Blood 126 (23), 54, 2015
42015
Inactivation of p53 provides a competitive advantage to del (5q) myelodysplastic syndrome hematopoietic stem cells during inflammation
T Muto, CS Walker, P Agarwal, E Vick, A Sampson, K Choi, M Niederkorn, ...
Haematologica 108 (10), 2715, 2023
32023
The system can't perform the operation now. Try again later.
Articles 1–20